(Reuters) – An experimental drug being developed by Roche Holding AG removed amyloid plaques from the brains of Alzheimer’s disease patients in a small early-stage study, according to data published in the Archives of Neurology, the Swiss drugmaker said on Monday.
Read the original here:
... continue reading
A commonly prescribed Alzheimer’s drug had no effect in treating patients with a mild form of the disease, U.S. researchers said on Monday, underscoring the need for new and better treatments for the most common form of dementia.
See more here:
... continue reading
A variant of an obesity gene carried by more than a third of the U.S. population also reduces brain volume, raising carriers’ risk of Alzheimer’s disease, U.S. researchers said on Monday.
Read more here:
Gene makes people fat, raises Alzheimer’s risk
People with a family history of Alzheimer‘s disease often have clumps of a toxic protein in their brains even though they are perfectly healthy, researchers said on Monday.
See the article here:
Brain scans show signs of early Alzheimer’s
People with a family history of Alzheimer’s disease often have clumps of a toxic protein in their brains even though they are perfectly healthy, researchers said on Monday.
Visit link:
Brain scans show signs of early ... continue reading